NASDAQ:URGN | Operating Income | UroGen Pharma Ltd.

Complete source-backed operating income history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30$111,000.00
2026-03-31-$20.26M
2025-12-31-$19.12M
2025-09-30-$27.39M
2025-06-30-$41.45M
2025-03-31-$36.91M
2024-12-31-$27.66M
2024-09-30-$17.55M
2024-06-30-$25.84M
2024-03-31-$25.74M
2023-12-31-$14.61M
2023-09-30-$13.5M
2023-06-30-$15.38M
2023-03-31-$22.05M
2022-12-31-$20.28M
2022-09-30-$18.09M
2022-06-30-$18.72M
2022-03-31-$21.96M
2021-12-31-$19.92M
2021-09-30-$23.44M
2021-06-30-$22.82M
2021-03-31-$26.11M
2020-12-31-$27.25M
2020-09-30-$29.12M
2020-06-30-$31.8M
2020-03-31-$38.56M
2019-12-31-$39.84M
2019-09-30-$23.45M
2019-06-30-$23.75M
2019-03-31-$22.43M
2018-12-31-$24.02M
2018-09-30-$21.09M
2018-06-30-$18.43M
2018-03-31-$13.64M
2017-12-31-$10.16M
2017-09-30-$303,000.00
2017-06-30-$5.95M
2017-03-31-$3.54M

Annual Operating Income

DateOperating Income
2025-12-31-$124.86M
2024-12-31-$96.78M
2023-12-31-$65.54M
2022-12-31-$79.04M
2021-12-31-$92.29M
2020-12-31-$126.74M
2019-12-31-$109.48M
2018-12-31-$77.18M
2017-12-31-$19.95M
2016-12-31$798,000.00
2015-12-31-$12.41M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.